— Experienced policy leader with expertise in disability rights and policy, advocacy, academia, and industry will help guide ICER in its mission to work towards a health system where everyone benefits from fair pricing, fair access, and future innovation —
March 12, 2024 – The Institute for Clinical and Economic Review (ICER) today announced the election of a new member to the ICER Governance Board: Henry Claypool. Mr. Claypool works as an independent consultant with clients in academia, civil society, philanthropy, government, and industry. He is also a visiting scientist at the Lurie Institute for Disability Policy in the Heller School at Brandeis University.
“Henry has had a remarkable career of service in academia, government, and industry,” said ICER’s President and CEO Sarah K. Emond, MPP. “His important work within the disability community will provide a valuable perspective to ICER as we continue to work towards fair pricing, fair access, and future innovation. We remain committed to continuous learning about how to center the lived experience of patients in our work. Henry’s guidance will broaden ICER’s current efforts to ensure we capture the patient experience comprehensively.”
Mr. Claypool stated, “Disability advocacy and disability rights are best understood by committing to inclusive practices; I am honored to serve on the ICER Governance Board as we work together to integrate these perspectives into ICER’s work. ICER’s commitment to transparency – to discussing consequential decisions about pricing and access of treatments in the open – is an important step towards ensuring that patients are at the center of discussions of value assessment.”
Henry Claypool has 30+ years of experience developing and implementing disability policy at the federal, state, and local level. His career in public service includes positions as the Director of the Health and Human Services Office on Disability and the founding Principal Deputy Administrator of the Administration for Community Living. He also served as a presidentially-appointed member of the Federal Commission on Long-Term Care, advising Congress on how long-term care can be better provided and financed for the nation’s older adults and people with disabilities, now and in the future. At the Health Care Financing Administration, now known as the Centers for Medicare and Medicaid Services, Mr. Claypool was the Senior Advisor to the Administrator for Disability Policy. Mr. Claypool previously was an Executive Vice President of the American Association of People with Disabilities (AAPD).
ICER’s Governance Board provides strategic counsel to ICER’s leadership team while maintaining fiduciary responsibility for the organization’s overall operations. For more information on ICER’s Governance Board, click here.
About ICER
The Institute for Clinical and Economic Review (ICER) is an independent non-profit research institute that produces reports analyzing the evidence on the effectiveness and value of drugs and other medical services. ICER’s reports include evidence-based calculations of prices for new drugs that accurately reflect the degree of improvement expected in long-term patient outcomes, while also highlighting price levels that might contribute to unaffordable short-term cost growth for the overall health care system.